Reversible neurotrophic keratopathy associated with rosuvastatin therapy: a case report.

CONCLUSION: Rosuvastatin may result in reversible trigeminal nerve impairment and neurotrophic keratopathy.
PMID: 31577084 [PubMed - in process]

Source: Journal of Population Therapeutics and Clinical Pharmacology - October 3, 2019 Category: Drugs & Pharmacology Tags: J Popul Ther Clin Pharmacol Source Type: research